Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0017638 (
glioma
)
30,880
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
A putative novel G protein-coupled receptor was isolated using the polymerase chain reaction (PCR) and conventional library screening. Degenerate primers corresponding to the thyroid and the sixth transmembrane regions that are conserved among the G protein-coupled receptors were used to amplify selectively gene fragments of new members of this receptor family from a neuroblastoma-
glioma
cell line cDNA. One of the PCR amplification products that by sequence analysis appeared to contain a partial fragment of a novel G protein-coupled receptor gene was used as a probe to screen a rat forebrain cDNA library to isolate a full-length clone. Sequence comparison indicates that the new gene belongs to the G protein-coupled receptor family and displays the highest structural similarity with the dog
RDC1
orphan receptor and several hormone peptide receptors. The mRNA for this putative receptor is not expressed in any specific region of the brain but seems to be localized in a restricted number of peripheral tissues, including lung, testes, and kidney. We suggest that the 4-24 cDNA clone encodes for a novel G protein-coupled receptor that may belong to hormone peptide receptor family.
...
PMID:A novel putative G protein-coupled receptor highly expressed in lung and testis. 839 Aug 39
More than 10 G protein-coupled receptors (GPCRs) have been shown to act as coreceptors for infection of human immunodeficiency virus type 1 (HIV-1), HIV-2, and simian immunodeficiency virus (SIV). We have isolated HIV-1 variants infectious to primary brain-derived CD4-positive cells (BT-3 and BT-20/N) and U87/CD4
glioma
cells that are resistant to T-cell line-tropic (T-tropic), macrophage-tropic (M-tropic), and T- and M-tropic (dualtropic) (X4, R5, and R5X4) HIV-1 strains. These primary brain-derived cells were also highly susceptible to HIV-2(ROD), HIV-2(SBL6669), and SIV(mndGB-1). A factor or coreceptor that determines the susceptibility of these brain-derived cells to these HIV and SIV strains has not been fully identified. To identify this coreceptor, we examined amino acid sequences of all known HIV and SIV coreceptors and noticed that tyrosine residues are well conserved in their extracellular amino-terminal domains. By this criterion, we selected 18 GPCRs as candidates of coreceptors for HIV and SIV strains infectious to these brain-derived cells. mRNA expression of an orphan GPCR,
RDC1
, was detected in the brain-derived cells, the C8166 T-cell line, and peripheral blood lymphocytes, all of which are susceptible to HIV-1 variants, but not in macrophages, which are resistant to them. When a CD4-expressing cell line, NP-2/CD4, which shows strict resistance to infection not only with HIV-1 but also with HIV-2 or SIV, was transduced with the
RDC1
gene, the cells became highly susceptible to HIV-2 and SIV(mnd) strains but to neither M- nor T-tropic HIV-1 strains. The cells also acquired a low susceptibility to the HIV-1 variants. These findings indicate that
RDC1
is a novel coreceptor for several HIV-1, HIV-2, and SIV strains which infect brain-derived cells.
...
PMID:A putative G protein-coupled receptor, RDC1, is a novel coreceptor for human and simian immunodeficiency viruses. 1062 23
Malignant gliomas are uniformly lethal tumors whose morbidity is mediated in large part by the angiogenic response of the brain to the invading tumor. This profound angiogenic response leads to aggressive tumor invasion and destruction of surrounding brain tissue as well as blood-brain barrier breakdown and life-threatening cerebral edema. To investigate the molecular mechanisms governing the proliferation of abnormal microvasculature in malignant brain tumor patients, we have undertaken a cell-specific transcriptome analysis from surgically harvested nonneoplastic and tumor-associated endothelial cells. SAGE-derived endothelial cell gene expression patterns from
glioma
and nonneoplastic brain tissue reveal distinct gene expression patterns and consistent up-regulation of certain
glioma
endothelial marker genes across patient samples. We define the G-protein-coupled receptor
RDC1
as a tumor endothelial marker whose expression is distinctly induced in tumor endothelial cells of both brain and peripheral vasculature. Further, we demonstrate that the
glioma
-induced gene, PV1, shows expression both restricted to endothelial cells and coincident with endothelial cell tube formation. As PV1 provides a framework for endothelial cell caveolar diaphragms, this protein may serve to enhance
glioma
-induced disruption of the blood-brain barrier and transendothelial exchange. Additional characterization of this extensive brain endothelial cell gene expression database will provide unique molecular insights into vascular gene expression.
...
PMID:Vascular gene expression in nonneoplastic and malignant brain. 1527 33